VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,696 | -20.4% | 3,296 | -10.9% | 0.00% | 0.0% |
| Q2 2023 | $111,378 | -23.5% | 3,699 | -17.8% | 0.00% | -25.0% |
| Q1 2023 | $145,608 | -7.7% | 4,501 | -18.3% | 0.00% | -20.0% |
| Q4 2022 | $157,831 | -44.0% | 5,507 | -52.8% | 0.01% | -50.0% |
| Q3 2022 | $282,000 | -24.8% | 11,675 | -14.9% | 0.01% | -16.7% |
| Q2 2022 | $375,000 | -58.3% | 13,712 | -41.5% | 0.01% | -53.8% |
| Q1 2022 | $899,000 | -28.8% | 23,440 | -40.6% | 0.03% | -27.8% |
| Q4 2021 | $1,263,000 | -14.1% | 39,450 | -20.9% | 0.04% | -30.8% |
| Q3 2021 | $1,470,000 | -24.5% | 49,880 | -13.0% | 0.05% | -26.8% |
| Q2 2021 | $1,948,000 | -14.6% | 57,345 | -18.3% | 0.07% | -20.2% |
| Q1 2021 | $2,280,000 | -51.6% | 70,164 | -46.3% | 0.09% | -53.9% |
| Q4 2020 | $4,709,000 | +4.7% | 130,744 | +13.8% | 0.19% | -5.4% |
| Q3 2020 | $4,499,000 | +29.9% | 114,906 | +21.7% | 0.20% | +17.2% |
| Q2 2020 | $3,464,000 | +174.7% | 94,427 | +72.6% | 0.17% | +126.0% |
| Q1 2020 | $1,261,000 | -1.2% | 54,702 | +25.5% | 0.08% | +18.5% |
| Q4 2019 | $1,276,000 | -0.9% | 43,590 | -9.6% | 0.06% | -11.0% |
| Q3 2019 | $1,288,000 | +747.4% | 48,240 | +723.2% | 0.07% | +711.1% |
| Q2 2019 | $152,000 | +17.8% | 5,860 | +1.7% | 0.01% | +12.5% |
| Q1 2019 | $129,000 | +4.9% | 5,760 | -1.7% | 0.01% | 0.0% |
| Q4 2018 | $123,000 | +13.9% | 5,860 | 0.0% | 0.01% | +33.3% |
| Q3 2018 | $108,000 | -74.1% | 5,860 | -68.6% | 0.01% | -77.8% |
| Q2 2018 | $417,000 | +2.0% | 18,685 | +0.5% | 0.03% | +3.8% |
| Q1 2018 | $409,000 | +34.5% | 18,585 | +41.8% | 0.03% | +36.8% |
| Q4 2017 | $304,000 | +1.0% | 13,110 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $301,000 | +24.9% | 13,110 | +20.1% | 0.02% | +18.8% |
| Q2 2017 | $241,000 | -3.2% | 10,915 | 0.0% | 0.02% | -5.9% |
| Q1 2017 | $249,000 | -33.6% | 10,915 | -39.1% | 0.02% | -34.6% |
| Q4 2016 | $375,000 | -13.6% | 17,915 | +9.1% | 0.03% | -18.8% |
| Q3 2016 | $434,000 | -16.7% | 16,415 | -12.7% | 0.03% | -17.9% |
| Q2 2016 | $521,000 | – | 18,798 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |